Scholar Rock (NASDAQ: SRRK; the "Company"), a late-stage biopharmaceutical company focused on advancing innovative treatments ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic ...
CAMBRIDGE, Mass., February 10, 2025--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA ...
Law professors have long debated what the term means. But now many have concluded that the nation faces a reckoning as ...
The All-Star guard paid a visit to his high school in Oakland and set up 9 nine students with $25,000 scholarships.
Kowbel's academic and personal achievements stood out, earning Kaylee a spot on the Honor Roll at Bard Academy this past fall ...
Shares in Scholar Rock have gone into overdrive after the biotech reported positive phase 3 results with apitegromab in patients with spinal muscular atrophy (SMA), setting up regulatory filings ...
India's Girish Malik is readying a docu-drama being presented at the European Film Market, which aims to offer ancient ...
The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...
Arabian Post on MSN1d
UM Scholars Make Scientific Discoveries with Global ImpactUM's faculty boasts leading scholars from diverse cultural backgrounds who are actively engaged in cutting-edge research in ...
The list of 2025 nominees for the Rock & Roll Hall of Fame announced on Wednesday reads like it was compiled by the unwoke ...
Karen Skinazi, Ph.D. is Associate Professor of Literature and Culture and the director of Liberal Arts at the University of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback